Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research].

Literature DB >> 3248329

[Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research].

Y X Ni.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1988 PMID： 3248329

Source DB: PubMed Journal: Zhong Xi Yi Jie He Za Zhi ISSN： 0254-9034

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

Review 1. Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors: Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal: J Med Chem Date: 2014-08-28 Impact factor: 7.446

2. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.

Authors: Shu-Jun Jiang; Hui Dong; Jing-Bin Li; Li-Jun Xu; Xin Zou; Kai-Fu Wang; Fu-Er Lu; Ping Yi
Journal: World J Gastroenterol Date: 2015-07-07 Impact factor: 5.742

3. Berberine acutely activates the glucose transport activity of GLUT1.

Authors: Alexandra Cok; Christina Plaisier; Matthew J Salie; Daniel S Oram; Jude Chenge; Larry L Louters
Journal: Biochimie Date: 2011-04-29 Impact factor: 4.079

4. Dietary berberine can ameliorate glucose metabolism disorder of Megalobrama amblycephala exposed to a high-carbohydrate diet.

Authors: Chang He; Xiaoyan Jia; Li Zhang; Fan Gao; Weibo Jiang; Chuang Wen; Cheng Chi; Xiangfei Li; Guangzhen Jiang; Haifeng Mi; Wenbin Liu; Dingdong Zhang
Journal: Fish Physiol Biochem Date: 2021-01-26 Impact factor: 2.794

[Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research].

Review 1. Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

2. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.

3. Berberine acutely activates the glucose transport activity of GLUT1.

4. Dietary berberine can ameliorate glucose metabolism disorder of Megalobrama amblycephala exposed to a high-carbohydrate diet.

5. Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism.

6. Efficacy of berberine in patients with type 2 diabetes mellitus.

7. Berberine improves glucose metabolism through induction of glycolysis.

8. Hypoglycemic activity of jatrorrhizine.

9. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model.

10. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.